CN106174193A - 一种含青梅的辅助降血脂的保健食品组合物及其制备方法 - Google Patents
一种含青梅的辅助降血脂的保健食品组合物及其制备方法 Download PDFInfo
- Publication number
- CN106174193A CN106174193A CN201610560924.6A CN201610560924A CN106174193A CN 106174193 A CN106174193 A CN 106174193A CN 201610560924 A CN201610560924 A CN 201610560924A CN 106174193 A CN106174193 A CN 106174193A
- Authority
- CN
- China
- Prior art keywords
- parts
- armeniaca mume
- mume sieb
- health
- blood fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000018795 Prunus mume Species 0.000 title claims abstract description 58
- 235000011158 Prunus mume Nutrition 0.000 title claims abstract description 58
- 210000004369 blood Anatomy 0.000 title claims abstract description 50
- 239000008280 blood Substances 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 230000001603 reducing effect Effects 0.000 title claims abstract description 37
- 235000013305 food Nutrition 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 239000000706 filtrate Substances 0.000 claims description 34
- 239000003755 preservative agent Substances 0.000 claims description 23
- 230000002335 preservative effect Effects 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 21
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 21
- 235000002949 phytic acid Nutrition 0.000 claims description 21
- 229940068041 phytic acid Drugs 0.000 claims description 21
- 239000000467 phytic acid Substances 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 21
- 229920001491 Lentinan Polymers 0.000 claims description 19
- 229940115286 lentinan Drugs 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 14
- 238000009413 insulation Methods 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 8
- 238000004064 recycling Methods 0.000 claims description 8
- 230000007159 enucleation Effects 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 210000004185 liver Anatomy 0.000 abstract description 15
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 6
- 230000000052 comparative effect Effects 0.000 description 45
- 239000003925 fat Substances 0.000 description 42
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 14
- 229960002855 simvastatin Drugs 0.000 description 14
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 238000003304 gavage Methods 0.000 description 12
- 238000002648 combination therapy Methods 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 108010010234 HDL Lipoproteins Proteins 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 8
- 108010007622 LDL Lipoproteins Proteins 0.000 description 8
- 102000007330 LDL Lipoproteins Human genes 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000011552 rat model Methods 0.000 description 6
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 5
- 240000007817 Olea europaea Species 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000003516 hyperlipidaemic effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 206010058646 Arcus lipoides Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- HWGBHCRJGXAGEU-UHFFFAOYSA-N Methylthiouracil Chemical compound CC1=CC(=O)NC(=S)N1 HWGBHCRJGXAGEU-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 101000800134 Rattus norvegicus Thyroglobulin Proteins 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 244000159501 Ximenia caffra Species 0.000 description 1
- 235000001365 Ximenia caffra Nutrition 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- -1 albumen Polymers 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960002545 methylthiouracil Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
- 229960003912 probucol Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3562—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3481—Organic compounds containing oxygen
- A23L3/3508—Organic compounds containing oxygen containing carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | TG(mmol/L) | TC(mmol/L) |
空白对照组 | 0.495±0.082 | 1.713±0.240 |
模型对照组 | 1.126±0.163** | 2.280±0.376** |
辛伐他汀组 | 0.593±0.086## | 1.851±0.229## |
实施例1组 | 0.973±0.102# | 2.030±0.271# |
实施例2组 | 0.985±0.108# | 2.024±0.290# |
实施例3组 | 0.930±0.099# | 1.997±0.273# |
对比例1组 | 1.084±0.147 | 2.169±0.362 |
对比例2组 | 1.124±0.158 | 2.276±0.402 |
对比例3组 | 1.021±0.103 | 2.091±0.349 |
组合治疗组 | 0.502±0.080## | 1.640±0.237## |
组别 | HDL(mmol/L) | LDL(mmol/L) |
空白对照组 | 1.227±0.096 | 0.846±0.174 |
模型对照组 | 0.832±0.065** | 1.542±0.168** |
辛伐他汀组 | 1.177±0.094## | 0.879±0.171## |
实施例1组 | 0.887±0.086# | 1.368±0.190 |
实施例2组 | 0.894±0.089# | 1.379±0.174 |
实施例3组 | 0.915±0.092# | 1.320±0.185# |
对比例1组 | 0.855±0.097 | 1.403±0.180 |
对比例2组 | 0.830±0.080 | 1.539±0.173 |
对比例3组 | 0.866±0.099 | 1.407±0.188 |
组合治疗组 | 1.209±0.094## | 0.853±0.173## |
组别 | ALT(mmol/L) | AST(mmol/L) |
空白对照组 | 17.70±2.259 | 20.50±3.270 |
模型对照组 | 38.10±3.862** | 35.80±4.532** |
辛伐他汀组 | 48.60±4.592** | 53.40±3.806** |
实施例1组 | 23.10±2.861## | 24.60±4.130## |
实施例2组 | 22.60±3.093## | 25.30±4.093## |
实施例3组 | 19.50±2.270## | 22.50±3.107## |
对比例1组 | 35.20±3.752 | 32.90±4.081 |
对比例2组 | 37.40±3.809 | 43.70±3.894 |
对比例3组 | 31.80±3.732 | 29.10±3.945 |
组合治疗组 | 24.00±2.963## | 25.70±3.972## |
组别 | Cr(mmol/L) | BUN(mmol/L) |
空白对照组 | 30.334±2.815 | 5.894±1.095 |
模型对照组 | 31.647±2.473 | 6.143±0.984 |
辛伐他汀组 | 32.364±2.490 | 6.245±1.104 |
实施例1组 | 30.792±2.506 | 6.013±1.090 |
实施例2组 | 31.073±2.125 | 6.071±1.103 |
实施例3组 | 30.390±1.809 | 5.947±1.008 |
组合治疗组 | 30.408±1.972 | 5.908±1.012 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610560924.6A CN106174193B (zh) | 2016-07-15 | 2016-07-15 | 一种含青梅的辅助降血脂的保健食品组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610560924.6A CN106174193B (zh) | 2016-07-15 | 2016-07-15 | 一种含青梅的辅助降血脂的保健食品组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106174193A true CN106174193A (zh) | 2016-12-07 |
CN106174193B CN106174193B (zh) | 2017-06-16 |
Family
ID=57475823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610560924.6A Active CN106174193B (zh) | 2016-07-15 | 2016-07-15 | 一种含青梅的辅助降血脂的保健食品组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106174193B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753520A (zh) * | 2017-11-21 | 2018-03-06 | 荣成市飞创科技有限公司 | 一种从鱿鱼内脏制备降血脂保健胶囊的方法 |
CN108743840A (zh) * | 2018-09-19 | 2018-11-06 | 烟台新时代健康产业有限公司 | 一种具有辅助降血脂功能的中药组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101263896A (zh) * | 2008-04-25 | 2008-09-17 | 周玉香 | 一种保健饮品及其制作方法 |
CN102423094A (zh) * | 2011-12-08 | 2012-04-25 | 刘聪 | 一种青梅饮料及其制备方法 |
CN104365922A (zh) * | 2013-08-17 | 2015-02-25 | 周型模 | 一种青梅保健茶 |
CN105638972A (zh) * | 2014-11-12 | 2016-06-08 | 南京龙力佳农业发展有限公司 | 一种青梅枸杞保健茶 |
-
2016
- 2016-07-15 CN CN201610560924.6A patent/CN106174193B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101263896A (zh) * | 2008-04-25 | 2008-09-17 | 周玉香 | 一种保健饮品及其制作方法 |
CN102423094A (zh) * | 2011-12-08 | 2012-04-25 | 刘聪 | 一种青梅饮料及其制备方法 |
CN104365922A (zh) * | 2013-08-17 | 2015-02-25 | 周型模 | 一种青梅保健茶 |
CN105638972A (zh) * | 2014-11-12 | 2016-06-08 | 南京龙力佳农业发展有限公司 | 一种青梅枸杞保健茶 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753520A (zh) * | 2017-11-21 | 2018-03-06 | 荣成市飞创科技有限公司 | 一种从鱿鱼内脏制备降血脂保健胶囊的方法 |
CN108743840A (zh) * | 2018-09-19 | 2018-11-06 | 烟台新时代健康产业有限公司 | 一种具有辅助降血脂功能的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106174193B (zh) | 2017-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106975069A (zh) | 一种保肝护肝组合物及其制备方法 | |
CN108522994A (zh) | 黄芪燕麦米粉 | |
CN101190280B (zh) | 梅树非果部分提取物的用途 | |
CN102715614A (zh) | 一种含有黑大蒜的新饮料 | |
JP6463504B2 (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
JP2972807B2 (ja) | 老化防止食品及びその製造法 | |
CN102715390A (zh) | 一种护肝功能食品及其制备方法 | |
CN106174193B (zh) | 一种含青梅的辅助降血脂的保健食品组合物及其制备方法 | |
CN1558768A (zh) | 一种中药组合物及其制备方法 | |
CN109125315A (zh) | 具有降血糖、降血脂和降血压作用的组合物及用途 | |
WO2015027730A1 (zh) | 显著升高血清高密度脂蛋白浓度的中药复合组合物和制备方法 | |
CN107213391A (zh) | 一种具有健脾养胃,消食调脂的药物组合物及其制备方法 | |
CN104524214B (zh) | 治疗消化道溃疡的中药组合物及其中药制剂、制备方法和应用 | |
CN108420890B (zh) | 一种具有降血脂作用的组合物及其制备方法 | |
CN107854656B (zh) | 一种降脂中药组合物及其制备方法和用途 | |
JPWO2005094858A1 (ja) | 抗糖尿病用組成物 | |
CN108271893A (zh) | 降血脂茶 | |
CN104585634A (zh) | 一种降压降脂米饼及其制作方法 | |
CN107751470A (zh) | 一种薏仁果味养生茶膏及其制备方法 | |
CN106605920A (zh) | 山竹酵素营养液及其制备方法 | |
CN106072099A (zh) | 一种含青梅的辅助降血脂的保健食品及其制备方法 | |
KR101344564B1 (ko) | 마라소스의 주성분인 고추 및 화초 추출물을 유효성분으로 함유하는 비만 또는 고지혈증 예방 및 치료용 조성물 | |
CN1460435A (zh) | 用女贞子和蚕蛹制成的护肝功能食品及其制备方法 | |
CN104758772A (zh) | 一种提高糖耐量的山姜花提取物及其用途 | |
CN104013696A (zh) | 一种防治代谢综合征的植物药组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiu Laigeng Inventor before: Qian Shuyuan Inventor before: Zou Weiquan Inventor before: Jiu Laigeng |
|
CB03 | Change of inventor or designer information | ||
CP03 | Change of name, title or address |
Address after: 518035 Guangdong city of Shenzhen province Futian District CaiTian road and Beihuan Avenue Interchange one Xinhao A block 2105, A2106 Patentee after: Shenzhen four seasons beautiful Industrial Co., Ltd. Address before: 518035 Shenzhen, Futian District Futian Street International Chamber of Commerce Center, layer 06, No. 22, No. Patentee before: SHENZHEN SIJIYOUMEI TRADE CO., LTD. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190611 Address after: 516300 Guangdong province Huizhou Huidong County Industrial Transfer Industrial Park Patentee after: Guangdong four seasons beautiful Industrial Co., Ltd. Address before: 518035 Caitian North Road and Beihuan Avenue, Futian District, Shenzhen City, Guangdong Province Patentee before: Shenzhen four seasons beautiful Industrial Co., Ltd. |
|
TR01 | Transfer of patent right |